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Early Experience with Stenting for Iliac Occlusive Disease 
G. J. Toogood 1, E. P. H. Torrie ~, T, R. Magee 2 and R. B. Galland ~1 
Departments of iSurgery and 2Radiology, Royal Berkshire Hospital, London Road, Reading, RG1 5AN, U.K. 
Objectives: To review our experience of iliac artery stenting for occlusive disease. 
Design" Prospective study of 50 consecutive patients with iliac occlusive disease, November 1993-November 1996. The 
indications for stenting were complete iliac occlusion (37) restenosis (four), donor site infiow for bypass grafting (four) 
and difficult stenoses (>90% and~or >5 cm) (five). The majority of patients (41) presented with intermittent claudication. 
Results: All 13 stenoses were successfully stented. One occluded but the rest remain patent. There were no other 
complications. By contrast, it was not possible to place a stent across 10 of the 37 complete iliac occlusions. In this group 
there were nine major complications, including five patients who required early embolectomy (four femoral, one brachial) 
and one patient who developed afalse aneurysm at the site of the stent. The "intention to treat" primary cumulative 
patency for iliac occlusions was 65% at 2 years but after excluding technical failures was 88%. 
Conclusions: There is a sharp learning curve and significant complication rate associated with stenting complete 
occlusions. However, following successful stenting patency rates are around 90% for both iliac stenoses and occlusions. 
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Introduction 
Aortoiliac occlusive disease has been successfully 
treated with percutaneous transluminal angioplasty 
(PTA) since the early 1980s. Increased acceptance of 
this technique reflects its simplicity, cost effectiveness 
and low incidence of significant complications. 1 Fail- 
ures and recurrences of iliac artery angioplasty do 
not increase the difficulty of subsequent procedures. 2 
However, restenoses, long and tight stenoses, dis- 
sections and occlusions have a major impact on results 
of iliac angioplasty. 3'4
The two main limitations of percutaneous trans- 
luminal balloon angioplasty appear to be intimal dis- 
section and elastic recoil. 1 Intravascular stents provide 
a mechanical means of overcoming these problems. 
With clearly defined indications for stent placement 
we report our early experience of iliac stenting and 
early complications encountered. 
Materials and Methods 
Data were collected prospectively on patients under- 
going iliac artery stenting for occlusive disease 
* Please address all correspondence to: R.B. Galland, Consultant 
Surgeon, Royal Berkshire Hospital, London Road, Reading, RG1 
5AN, U.K. 
between November 1993 and November 1996. Re- 
canalisation of the iliac artery was achieved by passing 
a guide-wire across the lesion using an ipsilateral 
Seldinger approach. The procedure took place under 
local anaesthetic in the Radiology department. An- 
gioplasty was performed using an undersized balloon 
(4mm) before insertion of a self expanding 
Wallstent (Schneider Europe, Zurich, Switzerland). 
Technical success was defined as restored patency 
and confirmed by a post-stenting digital subtraction 
angiogram (DSA). Whilst in hospital all patients re- 
ceived 5000 units bd subcutaneous heparin. Following 
treatment, patients were prescribed a daily dose of 
75 mg aspirin. Patients were reviewed in outpatients 
at 6 weeks. Intravenous DSA was carried out at 6 and 
12 months. 
During the 3-year period angioplasty with stenting 
was attempted in 50 patients (median age 61 years, 
range 45-89). There were 37 men. Forty-one patients 
presented with short distance intermittent clau- 
dication, four with rest pain and five with ischaemic 
ulcers. Five patients were diabetic. 
The indications for stenting were clearly defined: (i) 
complete occlusion, (n = 37), (ii) recurrent stenosis, (n = 
4), (iii) stenosis when iliac artery to be used as donor 
site for bypass grafting, (n =4), (iv) difficult stenosis 
(longer than 5 cm and/or tighter than 90%), (n = 5). In 
43 patients the common iliac artery was involved. All 
1078-5884/98/020165+04 $12.00/0 © 1998 W.B. Saunders Company Ltd. 
166 G.J. Toogood et al. 
30 
25-  
20-  
~ 15- 
o 
~ 10 z 
_ _  m 
m 
m 
1988 1989 1990 1991 1992 1993 1994 1995 1996 
Fig. 1. Numbers of AFBG (11); extra natomic bypass ([]); and stents (D) for iliac occlusive disease 1988-1996. 
of the 34 occlusions involved the whole length of the 
artery. In the other seven, lesions were confined to the 
external i iac artery (complete occlusion in three). The 
majority (34/50) of the disease was on the left side. 
Fifty-six Wallstents were used. In four patients more 
than one stent was required. The diameter of the stents 
ranged from 6 ram-12 mm (median 8 ram). 
Results 
It was not possible to stent 10 of the 37 complete iliac 
occlusions. In nine cases this was due to failure to pass 
a guide-wire across the lesion. In one, after successful 
positioning of the guide-wire an inadequate angio- 
plasty was performed. Nine of these technical failures 
occurred in the first 21 cases, including the first four 
attempted. Four of the 10 patients having a technical 
failure required subsequent operation. These included 
femorofemoral crossover grafts, one combined with a 
femoropopliteal bypass, and one combined aorto- 
femoral bifurcation and femoropopliteal bypass graft. 
Of those patients having attempted stenting of oc- 
clusions there were nine major complications. Eight 
occurred within 24 h of successful stent placement. 
Five patients required embolectomy (four femoral, one 
brachial). Two of the four femoral embolectomies and 
the brachial artery embolectomy were ipsilateral to 
the side of the stent. The patient with the brachial artery 
embolus developed a mild Volkmann's contracture but 
is able to use her arm and hand in a normal manner. 
Two stents occluded. One occlusion was thrombolysed 
with tPA which was only temporarily successful. The 
patient underwent aortofemoral bifurcation 3 weeks 
later following reocclusion of the stent. The other 
patient with an occluded stent underwent a femoro- 
femoral cross over graft the next day. Lysis was con- 
traindicated ue to a history of peptic ulcer disease. 
In one patient he iliac artery temporarily went into 
spasm. 
We have previously shown a decline in the use of 
aortofemoral bifurcation grafts for aorto iliac occlusive 
disease. 5 This was associated with an increase in the 
number of extra anatomic bypasses. The impact of 
iliac stenting, which has resulted in a reduction in extra 
anatomic bypasses performed since 1994, is shown in 
Fig. 1. 
One patient developed a false aneurysm adjacent to 
the proximal end of the stent 6 months after placement. 
This patient underwent an aortofemoral bifurcation 
graft. At operation the aneurysm was found to be 
saccular originating from the common iliac artery at 
the upper limit of the stent. The stent was patent. 
None of the patients in our series have suffered limb 
loss including the nine patients who presented with 
critical ischaemia. 
The "intention to treat" primary cumulative patency 
rate for the 37 occluded iliac arteries was 65% at 2 
years. The median follow up was 17 months, (range 
2-36). However, if technical failures are excluded 
this patiency rate increases to 88%, (Fig. 2). All 
patients with patient stents have improved symptoms 
and ankle:brachial pressure indices, (pre-procedure 
Eur J Vasc Endovasc Surg Vol 15, February 1998 
Early Experience with Stenting for Iliac Occlusive Disease 167 
27 
37 
100~ 
20 
90-  ~x 
80-  
70-  
60-  
5(] 
13 10 4 1 
__ 13 10 4 
I -  . . . . . . .  -D  . . . . . . . .  • . . . . . . . .  
I I I I 
6 12 18 24 30 
Months 
Fig. 2. Kaplan-Meier life table analysis of iliac artery occlusions 
with technically successful (--) and "intention to treat" (---) re- 
canalisation. The lines indicate cumulative patency rate and numbers 
of patients at risk. 95% confidence limits at 24 months: 67%, 96% 
(--) and 48%, 80% (---). 
median 0.5, range 0.4-0.8; post-procedure median 0.95, 
range 0.7-1.1. 
All 13 iliac artery stenoses were successfully stented. 
One stent occluded at 7 days and was cleared with 
tPA. It re-occluded at 21 months. The patient then 
underwent a femorofemoral  cross over graft. The re- 
maining stents (12/13) are patent at a median follow 
up of 17 months, (range 2-36). All but two patients are 
asymptomatic.  These two still have calf pain because of 
distal disease but refuse operation. 
All uncomplicated and successfully stented patients 
stayed in hospital for I night, as did those who had a 
technical failure. The median stay of patients with 
early complications was 5 nights (range 2-22). 
Discuss ion  
There are two aspects to successful endoluminal  
t reatment of any diseased artery. Firstly, mechanical  
crossing of the lesion, and secondly maintenance of 
patency. Passage of a guide-wire across the lesion is 
the critical step with complete occlusions, whether  
for angioplasty alone or combined with stent it> 
sertion. Our data show that there is learning curve 
in per forming this procedure,  as nine of the technical 
failures occurred in the first 21 patients with com- 
plete occlusions. Therefore, there has been successful 
p r imary  recanalisation i 16 of the last 17 per formed 
(88%). Others have experienced this learning curve. 
In a series of 103 iliac artery occlusions, Vorwerk et 
al. achieved a pr imary  recanalisation of 71% with the 
first 50 patients and 93% with the later 53 patients. 6 It 
is thought  that occlusions are due to severe ath- 
erosclerotic disease and proximal  thrombus.  Some 
centres have used thrombolysis  before attempt ing 
recanalisation with a guide-wire with encouraging 
results 7-9 (Table 1). 
The second area of discussion is long-term patency. 
Cumulative patency is usually calculated after re- 
jecting the technical failures which can give a mis- 
leading impression of success rate of stenting for iliac 
occlusions. Vorwerk et al. described a pr imary cumu- 
lative patency rate of 87% at 1 year and 54% at 5 
years. 6Long et al. reported pr imary cumulative patency 
rates of 90% and 41% at I and 4 years, respectively, but 
their data included iliac stenoses as well as occlusions. 
Secondary Cumulative patency rate refers to patency 
after additional or assisted patency procedures, such 
as angioplasty, thrombolysis or further stent insertion. 
Table 1. Summary of percutaneous angioplasty and/or stenting of iliac occlusive disease. 
No. of Stent 
Study lesions Lysis PTA placement 
Primary Secondary 
Primary cumulative cumulative 
recanalisation patency rate, patency rate, 
rate, % % (years) % (years) 
Ring is 10 0 5 0 50 80 (4) NG 
Colapinto 12 64 0 50 0 78 78 (4) NG 
Johnston 16 82 0 67 0 82 58 (3) NG 
Kichikawa s 5 5 5 5§ 100 100 (1.5) 100 (1.5) 
Long ~° 6411 0 0 63:~ 98 41 (4) 81 (4) 
Blum 9 47 47 43 18t 98 NG 87 (3) 
Vorwerk 6 127 0 0 103" 81 54 (5) 75 (5) 
This series 37 0 0 27* 73 88 (2) 88 (2) 
* Wallstent. 
t Palmaz stent. 
* Strecker stent. 
§ Gianturco stent. 
II Includes 28 iliac occlusions and 31 dissections. 
NG, not given. 
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In our series of occlusions only one stent underwent 
thrombolysis. This was unsuccessful. Therefore, our 
primary and secondary cumulative patency rates are 
the same. However, others have shown improvements 
in secondary cumulative patency rate 6-1° (Table 1). 
Despite regular angiography surveillance no restenosis 
has so far been detected in our series of occlusions or 
stenoses. 
We have previously shown that diabetic patients 
undergoing PTA are more likely to have disease below 
than above inguinal ligament, ll Diabetes has been 
shown to adversely effect results of angioplasty alone. 
Only five patients in this series were diabetic providing 
insufficient information regarding the influence of dia- 
betes on results of stenting. 
The most significant complication in our series has 
been peripheral emboli. It has been suggested that 
thrombolysis treatment prior to passing a guide-wire, 
angioplasty and stent insertion may reduce the rate 
of embolisation. However, embolisation rates vary 
between 0% to 40% with both stent insertions and 
angioplasty alone 6-1°'n'15'16 The embolisation rate in our 
study is high (5/27) but it is important o note that 
all of these patients have patent stents and only one 
experienced any long-term morbidity. It is likely that 
the brachial artery embolus was caused by the pigtail 
catheter being inserted too high. Complication rates 
for stented or angi0plastied iliac stenoses tend to be 
lower than for occlusionsJ 5 
Patency rates for stenting occlusions are at least 
as good as angioplasty alone, particularly secondary 
patency rates (Table 1). No prospective trials have 
been performed comparing stenting verses angioplasty 
alone for iliac occlusions. In a randomised trial for 
stenoses, Richter et al. improved technical success and 
better patency with stenting. I4
In our study, clear indications for stenting were 
defined. Others have used stents in the presence of 
vessel dissectionJ ° However, indications for stenting 
have yet to be completely identified. Its place in routine 
interventional radiology needs to be established with 
prospective studies. 
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